Indivior Pharmaceuticals Inc. Common Stock (SUPN) Stock Price Today
Cenovus Energy faces widened oil discount impacting Q4 2026 results but expects strong prices to offset losses.
Cenovus Energy is experiencing a widened discount to light oil, reaching $31.70, which will affect its fourth quarter results in fiscal year 2026. Management attributes this discount expansion mainly to temporary freight costs and is sticking to its ...
Oil prices rise amid US-Iran tensions and hopes for diplomatic talks post-midterms
Oil prices increased as investors considered the risk of renewed military conflict between the US and Iran following the US midterm elections, alongside emerging hopes for a diplomatic solution. Brent crude rose to $99.90 per barrel and US West Texas...
US likely to resume military action against Iran, pushing oil prices above $100 a barrel.
Bob McNally, CEO of Rapidan Energy Group, predicts an 80% chance of renewed US military action against Iran soon, which could drive Brent and West Texas Intermediate crude oil prices above $100 per barrel. This risk premium follows heightened tension...
Fermi's largest shareholder urges company sale amid board conflicts and plunging stock value.
Toby Neugebauer, Fermi Inc.'s co-founder and largest shareholder, criticized the company's board and called for an immediate sale of Fermi following a disappointing shareholder vote and a steep 80% drop in stock value. He highlighted the board's fail...
INOVIO prices $75M public offering to fund DNA medicine development.
INOVIO Pharmaceuticals announced a public offering of approximately 58.7 million shares and pre-funded warrants to raise about $75 million before expenses. The offering price is set at $1.05 per share, with an option for underwriters to buy additiona...
Ademi LLP probes Strategic Education for possible securities fraud amid 20% stock drop
Ademi LLP is investigating Strategic Education for potential securities fraud related to inaccurate statements about its financials and business operations, particularly in Australia. This probe follows a more than 20% decline in the company's stock ...
Corporate Insight names leaders in AI tools across financial services, highlighting Fidelity, Voya, Lively, Schwab, and Robinhood.
Corporate Insight released research identifying top financial firms leading in customer-facing AI tools, including virtual assistants and AI-powered fintech platforms. Fidelity and Voya lead in retirement plan virtual assistants, while Lively excels ...
Micron stock plunges 17.5% amid Taiwan union dispute, risking production and investor gains.
Micron's stock dropped 17.5% in one day due to a halted $4.5 billion memory plant project in Taiwan caused by a union pay dispute demanding 15% of operating profits. This threatens production as 60% of Micron's DRAM is made in Taiwan. Despite the dro...
MNTN misses Q3 earnings and cuts revenue forecast, shares plunge 45%.
MNTN reported third-quarter 2026 adjusted earnings of $0.10 per share, missing the $0.25 consensus, and revenue of $80.3 million, below guidance and analyst estimates. The company lowered its full-year revenue outlook due to sales execution challenge...
FDA grants accelerated approval to RYBREVANT FASPRO for advanced head and neck cancer treatment
Johnson & Johnson announced the FDA's accelerated approval of RYBREVANT FASPRO, a dual-targeted subcutaneous therapy for adults with recurrent or metastatic head and neck squamous cell carcinoma after platinum-based chemotherapy and anti-PD-(L)1 anti...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.